<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We examined the association of serum alanine aminotransferase (ALT) with features of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and whether it predicted incident <z:mp ids='MP_0002055'>diabetes</z:mp> independently of routinely measured factors in 5,974 men in the West of Scotland Coronary Prevention Study </plain></SENT>
<SENT sid="1" pm="."><plain>A total of 139 men developed new <z:mp ids='MP_0002055'>diabetes</z:mp> over 4.9 years of follow-up </plain></SENT>
<SENT sid="2" pm="."><plain>ALT, but not <z:chebi fb="0" ids="29995">aspartate</z:chebi> aminotransferase, levels increased progressively with the increasing number of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> abnormalities from (means +/- SD) 20.9 +/- 7.6 units/l in those with none to 28.1 +/- 10.1 units/l in those with four or more (P &lt; 0.001) </plain></SENT>
<SENT sid="3" pm="."><plain>In a univariate analysis, men with ALT in the top quartile (ALT &gt;/=29 units/l) had an elevated risk for <z:mp ids='MP_0002055'>diabetes</z:mp> (hazard ratio 3.38 [95% CI 1.99-5.73]) versus those in the bottom quartile (&lt;17 units/l) </plain></SENT>
<SENT sid="4" pm="."><plain>ALT remained a predictor with adjustment for age, BMI, <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi>, systolic blood pressure, <z:chebi fb="105" ids="17234">glucose</z:chebi>, and alcohol intake (2.04 [1.16-3.58] for the fourth versus first quartile) </plain></SENT>
<SENT sid="5" pm="."><plain>In stepwise regression, incorporating ALT and C-reactive protein (CRP) together with <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> criteria, elevated ALT (&gt;/=29 units/l), and CRP (&gt;/=3 mg/l) predicted incident <z:mp ids='MP_0002055'>diabetes</z:mp>, but <z:hpo ids='HP_0003233'>low HDL cholesterol</z:hpo> and <z:hpo ids='HP_0000822'>hypertension</z:hpo> did not </plain></SENT>
<SENT sid="6" pm="."><plain>Thus, <z:mp ids='MP_0002941'>elevated ALT levels</z:mp> within the "<z:mpath ids='MPATH_458'>normal</z:mpath>" range predict incident <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>The simplicity of ALT measurement and its availability in routine clinical practice suggest that this enzyme activity could be included in future <z:mp ids='MP_0002055'>diabetes</z:mp> prediction algorithms </plain></SENT>
</text></document>